An analysis of the 2009 HORIZONS-AMI trial found that the female participants who were treated with emergency stenting for heart attack had significantly higher rates of bleeding events than the men. The study presented at the Transcatheter Therapeutics meeting in November 2011, found bleeding at the catheter insertion site; in the abdomen, eyes and skull; bruising, unexplained drop in blood pressure and need for transfusion. However, the rate of adverse events, such as death, subsequent heart attack or stroke, or need for bypass surgery was similar in women and men.
To continue reading this article or issue you must be a paid subscriber.
Sign in
